Data Insights
By Company Name
No Filter Selected
By Disease Name
No Filter Selected
By Drug Name
No Filter Selected
By Themes
No Filter Selected
Showing 2 results out of 2
Data Insights
THN-391 by Therini Bio for Alzheimer's Disease: Likelihood of Approval
THN-391 is under clinical development by Therini Bio and currently in Phase I for Alzheimer's Disease. According to GlobalData, Phase...
Data Insights
THN-391 by Therini Bio for Dementia: Likelihood of Approval
THN-391 is under clinical development by Therini Bio and currently in Phase I for Dementia. According to GlobalData, Phase I...